SKETCHY USMLE Pharmacology 2020

Chapter 1 – Parasympathetic (3)

1.1 – Cholinomimetics (ONLY FOR MEMBER)

1.2 – Acetylcholinesterase Inhibitors

1.3 – Muscarinic antagonists (ONLY FOR MEMBER)

Chapter 2 – Sympathetic (4)

2.1 – Sympathomimetics

2.2 – Indirect sympathomimetics

2.3 – Alpha drugs

2.4 – Beta blockers

Chapter 1 – Heart Failure Drugs (2)

1.1 – Digoxin, milrinone, nesiritide (MEMBER)

1.2 – ACE inhibitors, ARBs, Aliskiren

Chapter 2 – Diuretics (4)

2.1 – Acetazolamide, mannitol (MEMBER)

2.2 – Loop diuretics

2.3 – Thiazides

2.4 – K+ sparing diuretics

Chapter 3 – Antihypertensives (2)

3.1 – Calcium channel blockers

3.2 – Primary hypertension & hypertensive emergency

Chapter 4 – Antiarrythmics (5)

4.1 – Class I A-C

4.2 – Class II

4.3 – Class III

4.4 – Class IV

4.5 – Class V

Chapter 1 – Anticoagulants & Thrombolytics (4)

1.1 – Heparin, LMWH, fondaparinux, direct thrombin inhibitors, Xa inhibitors (MEMBER)

1.2 – Warfarin

1.3 – Antiplatelet agents

1.4 – Thrombolytics

Chapter 2 – Dyslipidemia Drugs (3)

2.1 – Statins (MEMBER)

2.2 – Cholestyramine, ezetimibe

2.3 – Fibrates, niacin

Chapter 3 – Anti-Inflammatory (2)

3.1 – NSAIDs

3.2 – Gout drugs

Chapter 1 – Vasoactive (3)

1.1 – Nitrates (MEMBER)

1.2 – Triptans & migraine

1.3 – Prostaglandins, prostacyclin, bosentan, PDE5 inhibitors

Chapter 2 – Allergy & Pulmonary (2)

2.1 – Antihistamines

2.2 – Asthma therapy

Chapter 1 – GI (3)

1.1 – Antiemetic agents (MEMBER)

1.2 – H2 receptor blockers, PPIs

1.3 – Laxatives & antidiarrheal agents

Chapter 2 – Diabetes (2)

2.1 – Insulin, sulfonylureas, meglitinides, GLP-1 agonists, DPP-4 inhibitors

2.2 – Metformin, thiazolidinediones, pramlintide, SGLT2 inhibitors

Chapter 3 – Thyroid, Parathyroid & adrenal (4)

3.1 – Propylthiouracil, methimazole, levothyroxine

3.2 – Bisphosphonates, raloxifene, denosumab, calcitonin

3.3 – Teriparatide, vitamin D, cinacalcet, sevelamer

3.4 – Glucocorticoids

Chapter 4 – Hypethalamic & Pituitary (2)

4.1 – Growth hormone, mecasermin, octreotide, pegvisomant

4.2 – ADH, DDAVP, ADH receptor antagonists

Chapter 1 – Sedative-Hypnotics (3)

1.1 – Benzodiazepines, flumazenil (MEMBER)

1.2 – Nonbenzodiazepine hypnotics, melatonin, ramelteon

1.3 – Barbiturates

Chapter 2 – Anesthetics & Analgesics (3)

2.1 – Propofol, etomidate, ketamine

2.2 – Inhaled anesthetics, dantrolene

2.3 – Opiates, naloxone, naltrexone

Chapter 3 – Antidepressants & Anxiolytics (4)

3.1 – SSRIs, SNRIs, cyproheptadine (MEMBER)

3.2 – Tricyclic antidepressants

3.3 – MAO inhibitors

3.4 – Bupropion, mirtazapine, trazodone

Chapter 4 – Mood Stabilizers & Antiepileptics Drugs (4)

4.1 – Lithium

4.2 – Valproate, topiramate, lamotrigine, levetiracetam

4.3 – Carbamazepine, phenytoin, gabapentin, tiagabine, vigabatrin

4.4 – Ethosuximide

Chapter 5 – Antipsychotics & Parkinson’s (3)

5.1 – First generation antipsychotics

5.2 – Second generation antipsychotics

5.3 – Levodopacarbidopa, entacapone, tolcapone, selegiline, ropinirole, pramipexole, amantadine

Chapter 1 – Cell Wall and Membrane Active Antibiotics (7)

1.1 – Penicillin (MEMBER)

1.2 – Nafcillin, Oxacillin, Methicillin & Dicloxacillin

1.3 – Ampicillin, Amoxicillin, Piperacillin, Ticarcillin

1.4 – Cephalosporins

1.5 – Monobactams & Carbapenems (MEMBER)

1.6 – Vancomycin

1.7 – Daptomycin (MEMBER)

Chapter 2 – Inhibitors of Bacterial Protein Synthesis (6)

2.1 – Tetracyclines

2.2 – Macrolides

2.3 – Clindamycin

2.4 – Chloramphenicol

2.5 – Linezolid

2.6 – Aminoglycosides

Chapter 3 – Antimycobacterials (2)

3.1 – Tuberculosis Drugs

3.2 – Leprosy drugs

Chapter 4 – Other Antibiotics (3)

4.1 – Trimethoprim-Sulfamethoxazole

4.2 – Fluoroquinolones

4.3 – Metronidazole

Chapter 5 – Antifungals (3)

5.1 – Amphotericin, flucytosine

5.2 – Azoles

5.3 – Griseofulvin, Terbinafine, Echinocandins

Chapter 6 – Antivirals HIV (4)

6.1 – NRTIs

6.2 – NNRTIs

6.3 – Protease inhibitors

6.4 – Maraviroc, fusion inhibitors, integrase inhibitors

Chapter 7 – Antivirals Hepatitis (2)

7.1 – Interferon α, β, γ

7.2 – Ribavirin, sofosbuvir, simeprevir

Chapter 1 – Antimetabolites (3)

1.1 – Methotrexate, leucovorin, 5-fluorouracil, hydroxyurea

1.2 – Azathioprine, 6-mercaptopurine, mycophenolate mofetil

1.3 – Cladribine, cytarabine, gemcitabine

Chapter 2 – DNA & Cellular Division (5)

2.1 – Cyclophosphamide, ifosfamide, busulifan, nitrosoureas (carmustine, lomustine, streptozocin)

2.2 – Cisplatin, carboplatin, oxaliplatin, amifostine

2.3 – Bleomycin, doxorubicin, daunorubicin, actinomycin D

2.4 – Etoposide, teniposide, topotecan, irinotecan

2.5 – Vincristine, vinblastine, paclitaxel

Chapter 3 – Kinase Inhibitors & Monoclonal Antibodies (2)

3.1 – Imatinib, erlotinib, sorafenib, sunitinib, vemurafenib

3.2 – Rituximab, cetuximab, bevacizumab, alemtuzumab, trastuzumab

Chapter 4 – Immunology (1)

4.1 – Interferon α, β, γ